| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/07/1997 | CN1149255A Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 05/07/1997 | CN1149254A Pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections |
| 05/07/1997 | CN1149253A Use of N-alkyl derivatives of 1,5-dideoxy-1,5-imino-D-glucitol for the treatment of hepatitis B virus infections |
| 05/07/1997 | CN1149252A Novel substituted tryptamines, phenalkylamines and related compounds |
| 05/07/1997 | CN1149250A Improved anti-dandruff shampoo |
| 05/07/1997 | CN1149059A Preparation and application of sargassum polysaccharide complex |
| 05/07/1997 | CN1149051A Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha1 adrenergic receptor antagonists |
| 05/07/1997 | CN1149046A New substituted 2,2-dimethyl-omega-phenoxyalkanoic acids and esters, process for their preparation and pharmaceutical compositions containing them |
| 05/07/1997 | CN1148986A New skin preparation composition |
| 05/07/1997 | CN1148976A Antitussive liquid and preparation method |
| 05/07/1997 | CN1148958A Pharmaceutical application of glucoside A and B of auricledleaf swallowort |
| 05/07/1997 | CN1148957A Aqueously soluble powder preparation of taxinol and its preparing method |
| 05/07/1997 | CN1034810C 1,3-oxathiolane nucleoside analogues |
| 05/07/1997 | CN1034806C Process for preparing pyrimidinetrione |
| 05/07/1997 | CN1034805C Preparation of amino acid derivatives |
| 05/07/1997 | CA2189501A1 Nk-1 receptor antagonists for the treatment of cancer |
| 05/07/1997 | CA2189401A1 Purin-6-one derivatives |
| 05/06/1997 | USH1649 HIV protease inhibitor combinations |
| 05/06/1997 | US5627300 Epilepsy, muscle relaxants |
| 05/06/1997 | US5627285 Sulphonylbenzyl-substituted imidazolylpropenoic acid derivatives |
| 05/06/1997 | US5627278 Process for preparing compounds containing a fused bicyclic ring |
| 05/06/1997 | US5627274 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 05/06/1997 | US5627215 Unsaturate amino compounds for use as anticancer and antiprotozoic agent |
| 05/06/1997 | US5627212 Esters of L-carnitine and acyl L-carnitine with hydoxy acids for producing pharmcaeutical compositions for treating dermatoses |
| 05/06/1997 | US5627209 Use of certain 9-haloprostaglandins to treat glaucoma and ocular hypertension |
| 05/06/1997 | US5627208 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 05/06/1997 | US5627207 Cancer |
| 05/06/1997 | US5627205 Substituted phenoxyisobutyric acids and esters |
| 05/06/1997 | US5627203 Tricyclic oxime ethers |
| 05/06/1997 | US5627200 β3 -Adrenoceptor agonists and antagonists for the treatment of intestinal motility disorders, depression, prostate disease and dyslipidemia |
| 05/06/1997 | US5627199 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz [CD] indoles |
| 05/06/1997 | US5627198 Blood metal concentrations |
| 05/06/1997 | US5627197 Piperidino- or piperazino-substituted oxazolidinone, thiazolidinones or imidazolidinones |
| 05/06/1997 | US5627195 Tetrandrine |
| 05/06/1997 | US5627191 Therapeutic agents |
| 05/06/1997 | US5627187 Fluorouracil |
| 05/06/1997 | US5627186 Treatment of htlv or aids with 4-amino-1-(2-hydroxymethyl oxathiolan-5-yl)-1h-pyrimidin-2-one with 3'-azido-3'-deoxy thymidine |
| 05/06/1997 | US5627184 Methods of treating Giardia lamblia |
| 05/06/1997 | US5627183 Methods for treating urticaria using optically pure (+) cetirizine |
| 05/06/1997 | US5627182 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
| 05/06/1997 | US5627181 6-membered nitrogen-containing heteroaryl-oxazolidinones |
| 05/06/1997 | US5627180 Substituted thiosemicarbazonethiones |
| 05/06/1997 | US5627178 Treating central nervous system disorders |
| 05/06/1997 | US5627177 Anxiolytic |
| 05/06/1997 | US5627176 Substituted azetidinone compounds useful as hypocholesterolemic agents |
| 05/06/1997 | US5627173 Phosphonoacetic acid derivatives and their use for treating degenerative joint disorders |
| 05/06/1997 | US5627172 Antilipemic agents |
| 05/06/1997 | US5627171 Synergistic antimetastasis agents |
| 05/06/1997 | US5627170 Phosphonic acid compound containing heterocyclic substituents, pharmaceutical composition contains same and a method of treating calcium metabolism disturbance |
| 05/06/1997 | US5627168 Inhibition of the unidirectional efflux of the excitatory amino acid antagonist from the brain; antiepileptic and anxiolytic agents; schizophrenia, analgesics; neurodegenerative diseases |
| 05/06/1997 | US5627163 Treatment of traveller's diarrhea |
| 05/06/1997 | US5627162 Methods and means for control of proliferation of remnant cells following surgery |
| 05/06/1997 | US5627161 Uridine diphosphoglucose and 5-phosphoribosyl pyrophosphate a metabolic intermediate |
| 05/06/1997 | US5627160 L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents |
| 05/06/1997 | US5627158 Antisense oligonucleotides of human regulatory subunit RI-.sub.α of camp dependent protein kinases for the treatment of cancer |
| 05/06/1997 | US5627157 α-glycosyl hesperidin and its uses |
| 05/06/1997 | US5627153 Anti-fungal methods and materials |
| 05/06/1997 | US5627057 Inhibitor compounds of farnesyl-protein transferase and chemotherapeutic compositions containing the same, produced by strain ATCC 55532 |
| 05/06/1997 | US5626884 Treatment of sickle cell disease |
| 05/06/1997 | US5626883 Vitamin c supplements for immunology |
| 05/06/1997 | US5626880 Infusion preparation |
| 05/06/1997 | US5626879 Terfenadine oral granules |
| 05/06/1997 | US5626875 Stabilized galenic formulations comprising an acid labile benzimidazole compound and its preparation |
| 05/06/1997 | US5626872 Gelatin capsules with shell and plasticizers and hydrophilic matrix of pollyoxyethylene glycol with propylene glycol, propylene carbonate and/or glycerol |
| 05/06/1997 | US5626869 Pharmaceutical composition containing a defined lipid system |
| 05/06/1997 | US5626866 Drug-containing adhesive composite transdermal delivery device |
| 05/06/1997 | US5626865 Enzyme-orthokeratology |
| 05/06/1997 | US5626862 Drug delivery from polymer matrices by release from matrix by degradation of polymer |
| 05/06/1997 | US5626860 Treatment of diabetes and reduction of fat stores |
| 05/06/1997 | US5626855 Serine compounds, their preparation and their use in cosmetic or dermatological compositions |
| 05/06/1997 | US5626852 Composition containing body activated fragrance for contacting the skin and method of use |
| 05/06/1997 | US5626838 Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx |
| 05/06/1997 | US5626831 Treatment of viruses for upper respiratory infections |
| 05/06/1997 | CA2129143C Reversal of multi-drug resistance by tetraarylethylenes |
| 05/06/1997 | CA2098791C (s)-2,3-dihydropolyprenol, (s)-2,3-dihydropolyprenyl monophosphate, processes of preparing the same and agents for inhibiting the growth or metastasis of cancers comprising the same |
| 05/06/1997 | CA2001359C Methods for the treatment and prophylaxis of pneumocystis carinii pneumonia and other diseases and compounds and formulations for use in said methods |
| 05/05/1997 | WO1997017353A1 Process for the preparation of 3-halogenocephem derivatives |
| 05/03/1997 | CA2189222A1 Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmaceuticals |
| 05/02/1997 | EP0770613A1 Substituted Imidazolidin-2,4-dione der4ivatives as immunomodulators |
| 05/02/1997 | EP0770612A1 Terazosin crystalline polymorph and pharmaceutical compositions thereof |
| 05/02/1997 | EP0770609A1 Antiviral agent containing benzodithiin derivative as active ingredient |
| 05/02/1997 | EP0770606A1 Cis-epoxide derivate useful as irreversible HIV protease inhibitor and process for its preparation |
| 05/02/1997 | EP0770602A2 Crystals of piperidine derivatives, intermediates for production of the same, and process for producing the same |
| 05/02/1997 | EP0770577A1 Fullerene derivatives as free-radical scavengers |
| 05/02/1997 | EP0770399A2 Additives enhancing topical actions of therapeutic agents |
| 05/02/1997 | EP0770393A2 Prolongation of organ transplantation using rapamycin loaded donor splenocytes |
| 05/02/1997 | EP0770392A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in a pharmaceutical composition |
| 05/02/1997 | EP0770391A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in pharmaceutical compositions |
| 05/02/1997 | EP0770389A1 Use of monosialoganglioside GM1 or N-dichloro-acetyl-lyso-GM1 for preventing or reversing neuronal degeneration induced by a long term treatment with L-DOPA in the therapy of Parkinson's disease |
| 05/02/1997 | EP0770388A1 Multiphase contraceptive preparation based on natural estrogens |
| 05/02/1997 | EP0770387A1 Pharmaceutical composition containing a local anesthetic and/or centrally acting analgesic |
| 05/02/1997 | EP0770386A1 Lanperisone formulation |
| 05/02/1997 | EP0770385A1 Use of astaxanthin for the treatment of stress |
| 05/02/1997 | EP0770383A1 Ophthalmic cromolyn gel preparation |
| 05/02/1997 | EP0770381A1 Support and composition containing it together with a stabilised cosmetic or dermatologic agent |
| 05/02/1997 | EP0770378A1 Cosmetic preparations with an effective amount of glycosylglycerides |
| 05/02/1997 | EP0770140A1 Nucleic acid containing composition, preparation and uses of same |
| 05/02/1997 | EP0770132A1 Streptogramines and method for preparing same by mutasynthesis |
| 05/02/1997 | EP0770089A1 Growth differentiation factor-12 |
| 05/02/1997 | EP0770083A1 PYRIDO[3,2,1-i,j][3,1]BENZOXAZINE DERIVATIVES |